3 terminated, 1 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow WP 744: new trials by email Literature Review of WP 744 trials Research Report on WP 744
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases berubicin hydrochloride (RTA 744) - Brain Metastases | Phase 2 | Terminated | Biogen | 14 | 2007-10-31 | 2025-05-29 |
| A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis RTA 744 - Leptomeningeal Carcinomatosis | Phase 1 | Terminated | Biogen | 9 | 2006-10-31 | 2025-05-30 |
| RTA 744 Injection in Patients With Leptomeningeal Disease RTA 744 - Neoplastic Meningitis, Solid Tumor | Phase 1 | Terminated | M.D. Anderson Cancer Center | 7 | 2006-09-01 | 2016-05-16 |
| A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas RTA 744, RTA 744 injection - Glioma | Phase 1 | Completed | Biogen | 54 | 2005-11-30 | 2025-05-28 |
Brain Neoplasms (2) · Meningeal Carcinomatosis (2) · Breast Neoplasms (1) · Glioma (1) · Leukemia (1) · Lymphoma (1) · Meningeal Neoplasms (1)
Biogen (3) · M.D. Anderson Cancer Center (1)
United States (4)